Extra Super Levitra is a clinically formulated combination medication designed to address both erectile dysfunction and premature ejaculation concurrently. This advanced therapeutic solution leverages the synergistic action of two established active ingredients—Vardenafil and Dapoxetine—to provide comprehensive treatment for sexual health concerns. By targeting distinct physiological pathways, it facilitates improved erectile rigidity and prolonged intravaginal ejaculation latency time, offering a dual benefit approach for men experiencing these interrelated conditions. Its development represents a significant advancement in sexual medicine, providing a streamlined treatment option where previously multiple medications might have been required.

Features

• Contains Vardenafil Hydrochloride (20mg) and Dapoxetine Hydrochloride (60mg) per tablet
• Film-coated oral formulation for ease of administration
• Rapid onset of action, typically within 30-60 minutes post-ingestion
• Duration of therapeutic effect lasting up to 4-6 hours for the erectile component
• Manufactured under strict GMP (Good Manufacturing Practice) guidelines
• Available in blister packs ensuring product integrity and patient compliance

Benefits

• Achieves and sustains firm erections sufficient for sexual intercourse
• Significantly delays ejaculation, improving control and sexual satisfaction
• Addresses two common sexual dysfunctions with a single medication
• Reduces performance anxiety through reliable pharmacological support
• Enhances overall sexual experience for both partners
• Provides a predictable and consistent treatment response when used as directed

Common use

Extra Super Levitra is primarily prescribed for the treatment of male erectile dysfunction (ED) concomitant with premature ejaculation (PE). It is indicated for sexually active adult men who experience difficulty in achieving or maintaining an erection adequate for satisfactory sexual performance, simultaneously with a persistent or recurrent inability to control ejaculation, resulting in distress or interpersonal difficulty. The medication is intended for use prior to anticipated sexual activity and is not designed for continuous daily dosing. It should be employed within the context of a overall approach to sexual health, which may include psychological counseling or lifestyle modifications where appropriate.

Dosage and direction

The standard recommended dosage is one tablet taken orally with a full glass of water approximately 30-60 minutes before anticipated sexual activity. The tablet should be swallowed whole and not crushed, chewed, or broken. Administration may be with or without food, though a high-fat meal may delay the onset of action. The dosing should not exceed one tablet within a 24-hour period. dosage adjustments are generally not recommended without physician consultation. For optimal results, sexual stimulation is required to activate the pharmacological effect of the Vardenafil component.

Precautions

Patients should undergo a thorough medical evaluation prior to initiation to assess cardiovascular suitability, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. This medication may cause dizziness or syncope; patients should avoid hazardous activities until their response is known. Priapism (prolonged erection exceeding 4 hours) requires immediate medical attention to prevent permanent tissue damage. Not recommended for use with other treatments for erectile dysfunction or premature ejaculation.

Contraindications

Absolute contraindications include concomitant administration with nitrates or nitric oxide donors in any form due to risk of severe hypotension. Additional contraindications include hypersensitivity to Vardenafil, Dapoxetine, or any excipients; severe hepatic impairment; significant cardiac disease where sexual activity is inadvisable; and history of stroke or life-threatening arrhythmia within the last 6 months. Concomitant strong CYP3A4 inhibitors should be avoided.

Possible side effects

Common adverse reactions (≥1/100 to <1/10) include headache, flushing, nasal congestion, dyspepsia, dizziness, and nausea. Less frequently (≥1/1,000 to <1/100), visual disturbances, palpitations, orthostatic hypotension, insomnia, and anxiety may occur. Rare but serious side effects include sudden hearing loss, non-arteritic anterior ischemic optic neuropathy, and seizures. Most side effects are mild to moderate and transient in nature.

Drug interaction

Significant interactions occur with nitrates (contraindicated), alpha-blockers (increased hypotensive effects), strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir - avoid concomitant use), and moderate CYP3A4 inhibitors (e.g., erythromycin - requires caution). Concurrent use with other serotonergic drugs may increase risk of serotonin syndrome. Interactions with CYP2D6 inhibitors may increase Dapoxetine exposure.

Missed dose

As this medication is taken on an as-needed basis prior to sexual activity, the concept of a “missed dose” does not apply. Patients should not take an additional tablet to make up for a missed dose. The next dose should be taken at the next occasion of anticipated sexual activity, respecting the minimum 24-hour interval between doses.

Overdose

In case of suspected overdose, immediate medical attention should be sought. Symptoms may include severe headache, visual disturbances, prolonged erection, syncope, cardiovascular instability, and serotonergic effects such as agitation and confusion. Standard supportive measures should be employed; dialysis is not expected to be effective due to high protein binding. Specific treatments for prolonged erection may include corporal irrigation.

Storage

Store at room temperature (15-30°C) in the original packaging, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Do not transfer tablets to alternative containers as the blister packaging provides protection from environmental factors.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Extra Super Levitra is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Patients should disclose their full medical history and current medications to their prescribing physician. Individual results may vary based on physiological factors and adherence to dosing instructions.

Reviews

Clinical studies demonstrate significant improvement in both erectile function and ejaculatory control parameters compared to placebo. Patient-reported outcomes indicate high satisfaction rates with the dual-action approach. Many users report improved confidence and relationship satisfaction. Some note the convenience of a single tablet addressing multiple concerns. A minority of patients report side effects that led to discontinuation, primarily headache or dizziness. Overall efficacy and tolerability profile appears favorable in appropriate patient populations.